Brain Metabolic Changes of Cervical Dystonia with Spinocerebellar Ataxia Type 1 after Botulinum Toxin Therapy-Reference-Cited by-同舟云学术

Brain Metabolic Changes of Cervical Dystonia with Spinocerebellar Ataxia Type 1 after Botulinum Toxin Therapy

Published:2016 Issue:14 Volume:55 Page:1919-1922
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kikuchi Akio¹,Takeda Atsushi¹²,Sugeno Naoto¹,Miura Emiko¹,Kato Kazuhiro¹,Hasegawa Takafumi¹,Baba Toru¹,Konno Masatoshi¹,Oshima Ryuji¹,Watanuki Shoichi³,Hiraoka Kotaro³,Tashiro Manabu³,Aoki Masashi¹

Affiliation:

1. Department of Neurology, Tohoku University Graduate School of Medicine, Japan

2. Department of Neurology, National Hospital Organization Sendai-Nishitaga Hospital, Japan

3. Division of Cyclotron Nuclear Medicine, Cyclotron and Radioisotope Centre, Tohoku University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/55/14/55_55.5843/_pdf

Reference15 articles.

1. 1. Giladi N. The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site. J Neurol Sci 152: 132-135, 1997.

2. 2. Kanovsky P, Streitova H, Dufek J, Znojil V, Daniel P, Rektor I. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A. Mov Disord 13: 108-117, 1998.

3. 3. Ceballos-Baumann AO, Sheean G, Passingham RE, Marsden CD, Brooks DJ. Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study. Brain 120 (Pt 4): 571-582, 1997.

4. 4. Etgen T, Muhlau M, Gaser C, Sander D. Bilateral grey-matter increase in the putamen in primary blepharospasm. J Neurol Neurosurg Psychiatry 77: 1017-1020, 2006.

5. 5. Onodera Y, Aoki M, Tsuda T, et al. High prevalence of spinocerebellar ataxia type 1 (SCA1) in an isolated region of Japan. J Neurol Sci 178: 153-158, 2000.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety;Scientific Reports;2021-12

2. Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites;Scientific Reports;2020-07-30

3. Mystery of Expansion: DNA Metabolism and Unstable Repeats;Advances in Experimental Medicine and Biology;2020